Boston — Boston, Massachusetts

Boston is a clinical research site located in Boston, Massachusetts, United States 02115.

Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

Boston has participated in 7 clinical trials with 2 currently active.

Therapeutic areas: Clostridium Difficile Infection Recurrence, Non-infectious Anterior Uveitis, Uveitic Glaucoma.

Sponsors: Finch Research and Development LLC., Tarsier Pharma, Rebiotix Inc..

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Boston?

Boston has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Boston conducted?

Boston has 7 clinical trials on record, with 2 currently active. Their work covers Clostridium Difficile Infection Recurrence, Non-infectious Anterior Uveitis, Uveitic Glaucoma.

Is Boston accredited by Crixeo Health?

Yes — Boston holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Boston?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.